Successful treatment of renal cell carcinoma with sorafenib after effective but hepatotoxic sunitinib exposure

J Clin Oncol. 2013 Feb 20;31(6):e83-6. doi: 10.1200/JCO.2012.43.6485. Epub 2012 Nov 26.

Authors

Hans M Westgeest¹, Nielka P van Erp, Richard J Honeywell, Ronald Hoekstra, Godefridus J Peters, Henk M W Verheul

Affiliation

¹ VU University Medical Center, Amsterdam, The Netherlands.

PMID: 23182994
DOI: 10.1200/JCO.2012.43.6485

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Angiogenesis Inhibitors / adverse effects
Antineoplastic Agents / therapeutic use
Carcinoma, Renal Cell / drug therapy*
Carcinoma, Renal Cell / pathology
Chemical and Drug Induced Liver Injury / diagnosis
Chemical and Drug Induced Liver Injury / etiology
Humans
Indoles / adverse effects*
Liver Neoplasms / drug therapy*
Liver Neoplasms / pathology
Male
Niacinamide / analogs & derivatives*
Niacinamide / therapeutic use
Phenylurea Compounds / therapeutic use*
Pyrroles / adverse effects*
Sorafenib
Sunitinib
Treatment Outcome

Substances

Angiogenesis Inhibitors
Antineoplastic Agents
Indoles
Phenylurea Compounds
Pyrroles
Niacinamide
Sorafenib
Sunitinib